Clinical Trials Browser

Completed × Lymphoproliferative Disorders × Alemtuzumab × Clear all

Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00048412 2020-01-18

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Phase 1/2 Completed

40 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias

Clinical Trials

MOHEL

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H